Paul R Knight Selected Research

Paul R Knight Research Topics

Disease

21	Lung Injury 01/2017 - 04/2002
15	Pneumonia (Pneumonitis) 01/2017 - 09/2002
11	Inflammation (Inflammations) 04/2013 - 04/2002
10	Acute Lung Injury 01/2017 - 07/2005
6	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2017 - 01/2006
6	Infections 01/2016 - 11/2003
6	Wounds and Injuries (Trauma) 12/2009 - 01/2004
5	Human Influenza (Influenza) 01/2023 - 06/2010
5	Neuralgia (Stump Neuralgia) 07/2015 - 07/2002
5	Hyperalgesia 07/2015 - 07/2002
5	Surfactant Dysfunction 11/2008 - 09/2002
4	Pain (Aches) 07/2015 - 07/2002
4	Contusions 03/2013 - 08/2005
3	Necrosis 01/2023 - 08/2005
2	Bacterial Pneumonia 09/2015 - 09/2002
2	Chronic Granulomatous Disease 04/2013 - 03/2007
1	Virus Diseases (Viral Diseases) 03/2020
1	Communicable Diseases (Infectious Diseases) 11/2017
1	Respiratory Tract Infections (Respiratory Tract Infection) 09/2015
1	Endotoxemia 01/2015
1	Ischemia 01/2015
1	Reperfusion Injury 01/2015
1	Myocardial Ischemia (Ischemic Heart Diseases) 01/2015
1	Pulmonary Aspergillosis 04/2013
1	Mycoses (Diseases, Fungus) 04/2013
1	Porcine Reproductive and Respiratory Syndrome (PRRS) 01/2013
1	Aspiration Pneumonia 06/2011
1	Lung Diseases (Lung Disease) 02/2011
1	Asthma (Bronchial Asthma) 02/2009

Drug/Important Bio-Agent (IBA)

12	AcidsIBA 01/2017 - 10/2004
12	CytokinesIBA 04/2013 - 07/2002
11	AlbuminsIBA 09/2015 - 04/2005
8	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2015 - 07/2002
7	Proteins (Proteins, Gene)FDA Link 03/2020 - 09/2002
5	Surface-Active Agents (Surfactants)IBA 11/2008 - 04/2002
4	Oxidants (Oxidizing Agents)IBA 04/2013 - 04/2002
4	Virulence Factors (Pathogenicity Factors)IBA 09/2007 - 09/2003
3	Antiviral Agents (Antivirals)IBA 01/2023 - 03/2020
3	VaccinesIBA 01/2023 - 01/2016
3	Anesthetics (Anesthetic Agents)IBA 11/2017 - 04/2002
3	Hydrochloric Acid (Hydrogen Chloride)FDA Link 01/2017 - 10/2004
3	LipopolysaccharidesIBA 01/2015 - 09/2003
3	NADPH Oxidases (NAD(P)H oxidase)IBA 04/2013 - 03/2007
3	Peroxidase (Myeloperoxidase)IBA 08/2009 - 07/2005
3	Messenger RNA (mRNA)IBA 02/2009 - 07/2002
3	O Antigens (O Antigen)IBA 09/2007 - 09/2003
3	Capsules (Microcapsules)IBA 09/2007 - 09/2003
2	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 01/2023 - 04/2002
2	Caspase 3 (Caspase-3)IBA 01/2023 - 08/2005
2	Halothane (Fluothane)FDA Link 09/2015 - 04/2002
2	Dietary Advanced Glycation End ProductsIBA 09/2014 - 12/2012
2	Norepinephrine (Noradrenaline)FDA LinkGeneric 07/2013 - 03/2005
2	GoldIBA 09/2012 - 06/2010
2	ChemokinesIBA 08/2009 - 01/2006
2	GasesIBA 08/2009 - 07/2005
2	Hemolysin Proteins (Hemolysins)IBA 03/2007 - 08/2005
2	Interleukin-6 (Interleukin 6)IBA 07/2005 - 07/2004
2	Oxygen (Dioxygen)IBA 07/2005 - 09/2002
1	Propidium (Propidium Iodide)IBA 01/2023
1	Fluorescein (Funduscein)FDA LinkGeneric 01/2023
1	Annexin A5IBA 01/2023
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 03/2020
1	Ketamine FDA LinkGeneric 09/2015
1	Interferon Type IIBA 09/2015
1	salicylhydroxamic acid (SHAM)IBA 07/2015
1	Small Interfering RNA (siRNA)IBA 07/2015
1	Troponin IIBA 01/2015
1	EndotoxinsIBA 01/2015
1	Advanced Glycation End ProductsIBA 09/2014
1	Adenosine Triphosphate (ATP)IBA 07/2013
1	Superoxides (Superoxide)IBA 04/2013
1	ZymosanIBA 04/2013
1	GlucansIBA 04/2013
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 03/2013
1	Mitochondrial DNA (mtDNA)IBA 02/2013
1	imidazoleIBA 02/2013
1	TriterpenesIBA 02/2013
1	Reactive Oxygen Species (Oxygen Radicals)IBA 02/2013
1	Pattern Recognition ReceptorsIBA 10/2012
1	Immunoglobulins (Immunoglobulin)IBA 10/2012
1	Receptor for Advanced Glycation End ProductsIBA 10/2012
1	Complementary DNA (cDNA)IBA 09/2012
1	Chemotactic FactorsIBA 06/2012
1	CCR ReceptorsIBA 06/2012
1	ProcalcitoninIBA 06/2011
1	Anti-Bacterial Agents (Antibiotics)IBA 04/2011
1	Doxorubicin (Adriamycin)FDA LinkGeneric 02/2011
1	NanoconjugatesIBA 02/2011
1	Biomarkers (Surrogate Marker)IBA 12/2009
1	Interleukin-10 (Interleukin 10)IBA 08/2009
1	CollagenIBA 02/2009
1	Matrix Metalloproteinases (MMPs)IBA 02/2009
1	Tissue Inhibitor of Metalloproteinase-1IBA 02/2009
1	OvalbuminIBA 02/2009

Therapy/Procedure

4	Therapeutics 02/2011 - 02/2007
1	Tracheostomy 01/2017
1	Anesthesia 09/2015
1	Intraventricular Infusions 09/2012
1	Artificial Respiration (Mechanical Ventilation) 04/2011
1	Quantum Dots (Quantum Dot) 02/2011